Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun;132(6):692-697.
doi: 10.1016/j.amjmed.2018.12.038. Epub 2019 Jan 23.

Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?

Affiliations
Review

Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?

Islam Y Elgendy et al. Am J Med. 2019 Jun.

Abstract

Heart failure with preserved ejection fraction (HFpEF) is increasing in prevalence and has no guideline-recommended therapy, related in part to a lack of mechanism. Traditionally, HFpEF was thought to be secondary to afterload overload due to systemic hypertension; however, accumulating evidence suggests that HFpEF continues to worsen despite adequate control of blood pressure. Emerging data support the suggestion that myocardial ischemia secondary to coronary microvascular dysfunction could be the new paradigm pathophysiology. Several prospective, observational cohort studies indicate that the outcomes of patients with microvascular dysfunction, after an interval of several years, are dominated by HFpEF hospitalizations. Further, the most prevalent clinical phenotype (eg older women with multiple comorbidities) of patients with HFpEF resembles those with coronary microvascular dysfunction, albeit older. In this review, we provide in-depth insight about this emerging HFpEF paradigm, discuss potential therapeutic implications of this pathophysiology, and summarize some important knowledge gaps.

Keywords: Coronary artery disease; Heart failure; Ischemia; Microvascular dysfunction; Preserved ejection fraction.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None.

Figures

Figure 1
Figure 1
Pathogenic processes in HFpEF: Central role for microvascular ischemia. CMD = coronary microvascular disease; HFpEF = heart failure with preserved ejection fraction; VSM = vascular smooth muscle
Figure 2
Figure 2
Variable clinical course in coronary microvascular disease and heart failure with preserved function. Patients with multiple comorbidities, such as obesity and hypertension, develop progressive loss of coronary microvascular reserve secondary to the release of pro-inflammatory markers, which gradually worsens with years, until this reaches the threshold for ischemia, and then there will be gradual loss of the left ventricular diastolic reserve, which manifests later on with overt heart failure with preserved ejection fraction. HF = heart failure; IHD = ischemic heart disease; LV = left ventricular.

References

    1. Patel MR, Dai D, Hernandez AF, et al. Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J. 2014;167:846–852.e2. - PubMed
    1. Maddox TM, Stanislawski MA, Grunwald GK, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014;312:1754–1763. - PMC - PubMed
    1. Jespersen L, Hvelplund A, Abildstrom SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33:734–744. - PubMed
    1. Huang FY, Huang BT, Lv WY, et al. The prognosis of patients with nonobstructive coronary artery disease versus normal arteries determined by invasive coronary angiography or computed tomography coronary angiography: a systematic review. Medicine (Baltimore). 2016;95:e3117. - PMC - PubMed
    1. Shaw LJ, Merz CN, Pepine CJ, et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation. Circulation. 2006;114:894–904. - PubMed

Publication types